Korean J Perinatol.  2012 Jun;23(2):39-49.

Steroid use in Perinatal Medicine

Affiliations
  • 1Department of Pediatrics, Seoul National University College of Medicine, Seoul Seoul National University Boramae Hospital, Seoul, Korea. jinna@snu.ac.kr

Abstract

Steroid use in perinatal period consists of the prenatal betamethasone or dexamethasone, the hydrocortisone treatment for transient adrenal insufficiency, and the dexamethasone treatment for bronchopulmonary dysplasia. Antenatal steroid treatment is a standard therapy for impending preterm delivery. Antenatal steroid reduced mortality and severe morbidities including intraventricular hemorrhage and periventricular leukomalacia. Usually betamethasone was superior to dexamethasone. Postnatal hydrocortisone can be administered if hypotension cannot be recovered by volume challenge and maximal inotropics support. High-dose dexamethasone cannot be recommended for the treatment of bronchopulmonary dysplasia because of increased cerebral palsy. Further randomized controlled trials should be performed for the low-dose dexamethasone therapy for bronchopulmonary dysplasia.

Keyword

Steroid; Perinatal; Preterm

MeSH Terms

Adrenal Insufficiency
Betamethasone
Bronchopulmonary Dysplasia
Cerebral Palsy
Dexamethasone
Hemorrhage
Humans
Hydrocortisone
Hypotension
Infant, Newborn
Leukomalacia, Periventricular
Betamethasone
Dexamethasone
Hydrocortisone
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr